Hangzhou Jiuyuan Gene Engineering Co., Ltd.

杭州九源基因工程股份有限公司

02566.HK

Biopharmaceutical company in Zhejiang, China engaged in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices, focused on orthopedics, metabolic diseases, oncology and hematology; has eight marketed products including China's first rhBMP-2 bone repair material.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Connected or related major customers / suppliers
• Distribution model
• Single product, business line or region
• Government or SOE customers and tenders
• Pricing policy and price changes
• Particular sales arrangements
• Decline in revenue or profit
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Non-IFRS measures and adjustments
• Related-party transactions and balances
• Sanctioned countries and export controls
• Other